Generic drug approval: A US perspective

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.3, 2011-03, pp. : 541-545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of oncology drug approval between Health Canada and the US Food and Drug Administration

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1688-1693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration approval, clinical trials, and where we are today

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 10, 2014-10 ,pp. : 720-729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Under‐representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993‐2013

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 3025-3032

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug approval challenges in the age of personalized cancer treatment

By Schilsky Richard L

Personalized Medicine, Vol. 8, Iss. 6, 2011-11 ,pp. : 633-640

Future Medicine

Access to resources Recommend Favorite

Ethical Considerations in Orphan Drug Approval and Use

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 153-155

John Wiley & Sons Inc

Access to resources Recommend Favorite